Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SNDA · against 445 other Healthcare companies of similar size
Ranked #278 of 446 · scores higher than 37% of peers
Bars: peers in each 10-point band of the valuation score37 peers with a valuation score of 30–39, including SNDA · Click a bar to see the companies
Mainly because of its earnings yield, which is weaker than most Healthcare peers.
| Metric | SNDA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 434 reported | -16.7% | 1.5% | 9% | 30% | |
| EBITDA yieldHigher is better · 447 reported | 2.5% | 4.3% | 42% | 50% | |
| Free cash flow yieldHigher is better · 201 reported | -3.2% | -0.5% | 41% | 20% | |
| Book yieldHigher is better · 436 reported | 54.2% | 36.9% | 68% | Context only |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score